GeneThera, Inc. – OTC:GTHR

Add to watchlist

$0.015

+0.01

+15000%

Market closed

Open in about 7 hours

-100.00%

month

-100.00%

quarter

-100.00%

year

Market Cap	533.53K
Enterprise value	N/A

P/E	-0.4
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	-0.03
PEG ratio	92.86
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

GeneThera, Inc. (OTC:GTHR): Profit margin
Dec 2022	0	0
Mar 2023	0	0
Jun 2023	0	0
Sep 2023	0	0

GeneThera, Inc. (OTC:GTHR): Debt to assets
Sep 2022	1320	8.54M	647179.09%
Mar 2023	0	0
Jun 2023	0	0
Sep 2023	0	0

GeneThera, Inc. (OTC:GTHR): Cash Flow
Dec 2022	0	0	0
Mar 2023	0	0	0
Jun 2023	0	0	0
Sep 2023	0	0	0

GeneThera alternative data

GeneThera, Inc. (OTC:GTHR): Employee count
Aug 2023	2
Sep 2023	2
Oct 2023	2
Nov 2023	2
Dec 2023	2
Jan 2024	2
Feb 2024	2
Mar 2024	2
Apr 2024	2
May 2024	2
Jun 2024	2
Jul 2024	2

GeneThera, Inc. (OTC:GTHR): Insider trades (number of shares)
Period	Buy	Sel
Dec 2011	2690000	0
Jan 2012	12800008	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	4 Jan 2012	MILICI ANTONIO officer: Chairman..	Preferred B Stock	6,400,000	$0.02	$128,000
Purchase	4 Jan 2012	MILICI ANTONIO officer: Chairman..	Preferred B Stock	6,400,008	$0.02	$128,000
Purchase	31 Dec 2011	IRIZARRY TANNYA L officer: Chief Ad..	Preferred B Stock	2,690,000	$0.04	$107,600
Purchase	25 Feb 2008	MCNECE ELMER ROY JR 10 percent owner 10 percent owner	Common Stock	200,000	$0.03	$5,000
Purchase	19 Feb 2008	MCNECE ELMER ROY JR 10 percent owner 10 percent owner	Common Stock	135,000	$0.02	$2,970
Sale	22 Jan 2008	MCNECE ELMER ROY JR 10 percent owner 10 percent owner	Common Stock	20,000	$0.02	$460
Purchase	17 Jan 2008	MCNECE ELMER ROY JR 10 percent owner 10 percent owner	Common Stock	6,000	$0.03	$156
Purchase	15 Jan 2008	MCNECE ELMER ROY JR 10 percent owner 10 percent owner	Common Stock	100,000	$0.03	$2,800
Purchase	15 Jan 2008	MCNECE ELMER ROY JR 10 percent owner 10 percent owner	Common Stock	25,000	$0.03	$700
Purchase	15 Jan 2008	MCNECE ELMER ROY JR 10 percent owner 10 percent owner	Common Stock	50,000	$0.03	$1,350

GeneThera
Executives

Insider	Age	Since	Compensation
Dr. Antonio Milici (1955) Founder, Chairman, Chief Executive Officer, Pres & Chief Scientific Officer	70		$258,000
Ms. Tannya L. Irizarry (1960) Chief Admin. Officer, Interim Chief Financial Officer, Sec. & Compliance Officer	65		$208,000

Frequently Asked Questions (FAQ)

What's the price of GeneThera stock today?

One share of GeneThera stock can currently be purchased for approximately $0.02.
When is GeneThera's next earnings date?

Unfortunately, GeneThera's (GTHR) next earnings date is currently unknown.
Does GeneThera pay dividends?

No, GeneThera does not pay dividends.
How much money does GeneThera make?

GeneThera has a market capitalization of 533.53K.
What is GeneThera's stock symbol?

GeneThera, Inc. is traded on the OTC under the ticker symbol "GTHR".
What is GeneThera's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of GeneThera?

Shares of GeneThera can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are GeneThera's key executives?
GeneThera's management team includes the following people:
- Dr. Antonio Milici Founder, Chairman, Chief Executive Officer, Pres & Chief Scientific Officer(age: 70, pay: $258,000)
- Ms. Tannya L. Irizarry Chief Admin. Officer, Interim Chief Financial Officer, Sec. & Compliance Officer(age: 65, pay: $208,000)
Is GeneThera founder-led company?

Yes, GeneThera is a company led by its founder Dr. Antonio Milici.
How many employees does GeneThera have?

As Jul 2024, GeneThera employs 2 workers.
When GeneThera went public?

GeneThera, Inc. is publicly traded company for more then 13 years since IPO on 25 Sep 2012.
What is GeneThera's official website?

The official website for GeneThera is genethera.net.
Where are GeneThera's headquarters?

GeneThera is headquartered at 3051 West 105th Avenue, Westminster, CO.
How can i contact GeneThera?

GeneThera's mailing address is 3051 West 105th Avenue, Westminster, CO and company can be reached via phone at +7 205875100.

GeneThera, Inc.

genethera.net

Exchange:

OTC

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.

+7 205875100

3051 West 105th Avenue
Westminster, CO 80035

CIK: 0001017110
ISIN: US37185E3062
CUSIP: 37185E306